Nottingham Covid Research Group

We are proud to be supporting the ISARIC Consortium

Search

Glenn Hearson
- May 18, 2020
- 1 min read

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Professor Gisli Jenkins Lancet Respiratory publication doi.org/10.1016/S2213-2600(20)30225-3 "Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy" is now available "online first"

Click on the image to download

https://doi.org/10.1016/S2213-2600(20)30225-3

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

633 views1 comment

Recent Posts

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for #COVID-19

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease

Two Phenotypes of ARDS in severe COVID-19; Viral Pneumonia and Immune Mediated